Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group

P. Comella, E. Crucitta, F. De Vita, L. De Lucia, A. Farris, F. Del Gaizo, S. Palmeri, A. Iannelli, S. Mancarella, S. Tafuto, L. Maiorino, F. Buzzi, G. De Cataldis, R. Casaretti, A. Avallone, M. Montella, G. Comella, M. Orditura, G. Catalano, V. LorussoM. De Lena, M. Biglietto, G. Sanna, M. G. Sarobba, C. Belli, A. Russo, V. Pizzardi, V. Accurso, A. Musca, A. Gravina, G. Leopaldi, C. Brunetti, D. Muci, S. Leo, F. Avino, L. De Luca, E. Greco, C. Aiello

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences